| 4 January 2021 | Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme
| Gunn, H; Stevens, KN; Creanor, ES; et al. |
| 27 July 2017 | Balance Right in Multiple Sclerosis (BRiMS): A guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial
| Gunn, H; Andrade, J; Paul, L; et al. |
| 1 February 2015 | The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
| Ball, Susan; Vickery, J; Hobart, J; et al. |
| 2 August 2019 | Evaluation of a home-based standing frame programme in people with progressive Multiple Sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis
| Freeman, JA; Hendrie, W; Jarrett, L; et al. |
| 1 June 2019 | A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
| Gunn, H; Andrade, J; Paul, L; et al. |
| 7 October 2019 | Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study
| Carroll, CB; Webb, D; Stevens, KN; et al. |
| 2016 | Standing up in Multiple Sclerosis (SUMS): Protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
| Freeman, JA; Hendrie, W; Creanor, S; et al. |
